HCL and IBM expand alliance to help organizations with digital transformation

The IBM Ecosystem Unit of HCL will help clients leverage IBM Cloud capabilities to transform mission-critical workloads Noida, India and Sunnyvale, CA — October 1, 2020 — HCL Technologies (HCL), today announced a new collaboration with IBM (NYSE: IBM) to help clients accelerate their digital transformation by migrating enterprise mission-critical workloads to the IBM public cloud. The IBM Ecosystem Unit (IEU) at HCL will assist clients, including those enterprises in regulated industries such as financial services, telecommunications, life sciences & healthcare and energy & utilities, to develop digital and cloud-native solutions that will help advance their cloud journeys. These solutions will be built on the IBM public cloud using IBM Cloud Paks, containerized software running on Red Hat OpenShift, and Watson-powered advanced data and analytics. HCL’s IEU will offer a wide spectrum of services and solutions, leveraging IBM Cloud, data & analytics, artificial intelligence, machine learning capabilities and security to foster innovation for enterprises. Clients can participate in design workshops and remotely access the best technology from the company’s Cloud Native Labs located in the United States (Dallas), United Kingdom (London) and India (NCR), which fully support IBM Cloud and Red Hat environments for proof of concepts and solution building. “In line with HCL’s vision and strategy, this new chapter in our relationship with IBM is an affirmation of our strategy in responding to a changing world. Leveraging the IBM public cloud will enable HCL to work with enterprises in regulated industries such as financial services.” said Kalyan Kumar, Corporate Vice President and Chief Technology Officer, IT Services, HCL Technologies. “Currently our DRYiCETM portfolio runs on IBM public cloud. This collaboration will be extended to HCL’s product portfolio, which includes the development of new SaaS offerings on IBM Cloud.” “We see increased demand for companies in many industries with sensitive data, such as financial services and telco, to migrate their critical workloads and applications to the cloud,” said Bob Lord, Senior Vice President, Cognitive Applications, Blockchain and Ecosystems, IBM. “I see the flexibility and security of IBM’s hybrid cloud platform built with Red Hat OpenShift at the core, combined with HCL’s expertise in technology services, as a clear differentiator. Together, we can help clients maximize value and accelerate their digital transformation to any cloud environment, including the IBM public cloud.” HCL is part of IBM’s hybrid cloud ecosystem, an initiative to support global system integrators and independent software vendors that will help clients modernize workloads with Red Hat OpenShift for any cloud environment, including the IBM public cloud. The IBM public cloud is one of the industry’s most secure and open public clouds for business. With its security leadership, enterprise-grade strength and support for open source technologies, the IBM public cloud is designed to differentiate and extend on hybrid cloud workloads for enterprise workloads. About HCL Technologies HCL Technologies (HCL) empowers global enterprises with technology for the next decade today. HCL’s Mode 1-2-3 strategy through its deep-domain industry expertise, customer-centricity and entrepreneurial culture of ideapreneurship™ enables businesses transform into next-gen enterprises. HCL offers its services and products through three business units – IT and Business Services (ITBS), Engineering and R&D Services (ERS) and Products & Platforms (P&P). ITBS enables global enterprises to transform their businesses through offerings in areas of Applications, Infrastructure, Digital Process Operations and next generational digital transformation solutions. ERS offers engineering services and solutions in all aspects of product development and platform engineering while under P&P, HCL provides modernized software products to global clients for their technology and industry specific requirements. Through its cutting-edge co-innovation labs, global delivery capabilities and broad global network, HCL delivers holistic services in various industry verticals, categorized under Financial Services, Manufacturing, Technology & Services, Telecom & Media, Retail & CPG, Life Sciences & Healthcare and Public Services. As a leading global technology company, HCL takes pride in its diversity, social responsibility, sustainability and education initiatives. As of 12 months ended June 30, 2020, HCL has a consolidated revenue of US $ 9.93 billion and its 150,287 ideapreneurs operate out of 49 countries. For more information, visit https://www.hcltech.com/ Forward–looking Statements Certain statements in this release are forward-looking statements, which involve a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from those in such forward-looking statements. All statements, other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to the statements containing the words ‘planned’, ‘expects’, ‘believes’,’ strategy’, ‘opportunity’, ‘anticipates’, ‘hopes’ or other similar words. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding impact of pending regulatory proceedings, fluctuations in earnings, our ability to manage growth, intense competition in IT services, business process outsourcing and consulting services including those factors which may affect our cost advantage, wage increases in India, customer acceptances of our services, products and fee structures, our ability to attract and retain highly skilled professionals, our ability to integrate acquired assets in a cost-effective and timely manner, time and cost overruns on fixed-price, fixed-timeframe contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, the success of our brand development efforts, liability for damages on our service contracts, the success of the companies /entities in which we have made strategic investments, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property, other risks, uncertainties and general economic conditions affecting our industry. There can be no assurance that the forward-looking statements made herein will prove to be accurate, and issuance of such forward-looking statements should not be regarded as a representation by the Company, or any other person, that the objective and plans of the Company will be achieved. All forward-looking statements made herein are based on information presently available to the Management of the Company and the Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company. For further details, please contact: Lowell EschenIBM Media Relations+1 303 913 2569Lowell.Eschen@ibm.com HCL Technologies Anne Coyle, USAnne.coyle@hcl.com Elka Ghudial, EuropeElka.ghudial@hcl.com Devneeta Pahuja, India and APACDevneeta.p@hcl.com

The IBM Ecosystem Unit of HCL will help clients leverage IBM Cloud capabilities to transform mission-critical workloads

Noida, India and Sunnyvale, CA — October 1, 2020 — HCL Technologies (HCL), today announced a new collaboration with IBM (NYSE: IBM) to help clients accelerate their digital transformation by migrating enterprise mission-critical workloads to the IBM public cloud. The IBM Ecosystem Unit (IEU) at HCL will assist clients, including those enterprises in regulated industries such as financial services, telecommunications, life sciences & healthcare and energy & utilities, to develop digital and cloud-native solutions that will help advance their cloud journeys. These solutions will be built on the IBM public cloud using IBM Cloud Paks, containerized software running on Red Hat OpenShift, and Watson-powered advanced data and analytics.

HCL’s IEU will offer a wide spectrum of services and solutions, leveraging IBM Cloud, data & analytics, artificial intelligence, machine learning capabilities and security to foster innovation for enterprises. Clients can participate in design workshops and remotely access the best technology from the company’s Cloud Native Labs located in the United States (Dallas), United Kingdom (London) and India (NCR), which fully support IBM Cloud and Red Hat environments for proof of concepts and solution building.

“In line with HCL’s vision and strategy, this new chapter in our relationship with IBM is an affirmation of our strategy in responding to a changing world. Leveraging the IBM public cloud will enable HCL to work with enterprises in regulated industries such as financial services.” said Kalyan Kumar, Corporate Vice President and Chief Technology Officer, IT Services, HCL Technologies. “Currently our DRYiCETM portfolio runs on IBM public cloud. This collaboration will be extended to HCL’s product portfolio, which includes the development of new SaaS offerings on IBM Cloud.”

“We see increased demand for companies in many industries with sensitive data, such as financial services and telco, to migrate their critical workloads and applications to the cloud,” said Bob Lord, Senior Vice President, Cognitive Applications, Blockchain and Ecosystems, IBM. “I see the flexibility and security of IBM’s hybrid cloud platform built with Red Hat OpenShift at the core, combined with HCL’s expertise in technology services, as a clear differentiator. Together, we can help clients maximize value and accelerate their digital transformation to any cloud environment, including the IBM public cloud.”

HCL is part of IBM’s hybrid cloud ecosystem, an initiative to support global system integrators and independent software vendors that will help clients modernize workloads with Red Hat OpenShift for any cloud environment, including the IBM public cloud. The IBM public cloud is one of the industry’s most secure and open public clouds for business. With its security leadership, enterprise-grade strength and support for open source technologies, the IBM public cloud is designed to differentiate and extend on hybrid cloud workloads for enterprise workloads.

About HCL Technologies

HCL Technologies (HCL) empowers global enterprises with technology for the next decade today. HCL’s Mode 1-2-3 strategy through its deep-domain industry expertise, customer-centricity and entrepreneurial culture of ideapreneurship™ enables businesses transform into next-gen enterprises.

HCL offers its services and products through three business units – IT and Business Services (ITBS), Engineering and R&D Services (ERS) and Products & Platforms (P&P). ITBS enables global enterprises to transform their businesses through offerings in areas of Applications, Infrastructure, Digital Process Operations and next generational digital transformation solutions. ERS offers engineering services and solutions in all aspects of product development and platform engineering while under P&P, HCL provides modernized software products to global clients for their technology and industry specific requirements. Through its cutting-edge co-innovation labs, global delivery capabilities and broad global network, HCL delivers holistic services in various industry verticals, categorized under Financial Services, Manufacturing, Technology & Services, Telecom & Media, Retail & CPG, Life Sciences & Healthcare and Public Services.

As a leading global technology company, HCL takes pride in its diversity, social responsibility, sustainability and education initiatives. As of 12 months ended June 30, 2020, HCL has a consolidated revenue of US $ 9.93 billion and its 150,287 ideapreneurs operate out of 49 countries. For more information, visit https://www.hcltech.com/

Forward–looking Statements

Certain statements in this release are forward-looking statements, which involve a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from those in such forward-looking statements. All statements, other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to the statements containing the words ‘planned’, ‘expects’, ‘believes’,’ strategy’, ‘opportunity’, ‘anticipates’, ‘hopes’ or other similar words. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding impact of pending regulatory proceedings, fluctuations in earnings, our ability to manage growth, intense competition in IT services, business process outsourcing and consulting services including those factors which may affect our cost advantage, wage increases in India, customer acceptances of our services, products and fee structures, our ability to attract and retain highly skilled professionals, our ability to integrate acquired assets in a cost-effective and timely manner, time and cost overruns on fixed-price, fixed-timeframe contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, the success of our brand development efforts, liability for damages on our service contracts, the success of the companies /entities in which we have made strategic investments, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property, other risks, uncertainties and general economic conditions affecting our industry. There can be no assurance that the forward-looking statements made herein will prove to be accurate, and issuance of such forward-looking statements should not be regarded as a representation by the Company, or any other person, that the objective and plans of the Company will be achieved. All forward-looking statements made herein are based on information presently available to the Management of the Company and the Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.

For further details, please contact:

Lowell Eschen
IBM Media Relations
+1 303 913 2569
Lowell.Eschen@ibm.com

HCL Technologies

Anne Coyle, US
Anne.coyle@hcl.com

Elka Ghudial, Europe
Elka.ghudial@hcl.com

Devneeta Pahuja, India and APAC
Devneeta.p@hcl.com

This post was originally published on this site



For enquiries, product placements, sponsorships, and collaborations, connect with us at hello@globalcloudplatforms.com. We'd love to hear from you!


Our humans need coffee too! Your support is highly appreciated, thank you!

Total
0
Shares
Previous Article

BCI in Collaboration with IBM Advances Blockchain based Financial Services with Electronic Letter of Guarantee for Clients in Thailand

Next Article

3 cloud architecture secrets your cloud provider won’t tell you

Related Posts

IBM and The Climate Service to Work Together with Financial Institutions and Corporations to Assess the Cost of Climate Risk

Collaboration to Provide Organizations an IBM Cloud-based Platform to Measure, Quantify and Disclose Climate Risk ARMONK, N.Y. and DURHAM, N.C., Oct. 14, 2020 /PRNewswire/ -- IBM (NYSE: IBM) and The Climate Service (TCS), a leader in climate risk analytics for investors and businesses, today announced their alliance to work with financial institutions and corporations to better measure and quantify risks associated with climate change. As part of the alliance, the companies are now making the TCS Climanomics® software platform available via Red Hat OpenShift on IBM Cloud. This alliance between IBM and TCS makes TCS's advanced science available with enterprise-grade levels of scalability, availability, security, and interoperability. The companies are working together to help organizations put a price on climate risk and facilitate reporting consistent with the Task Force on Climate-Related Financial Disclosures (TCFD) framework. The alliance will also leverage the experience of IBM Services in financial risk, analytics, weather risk, and compliance, to use the Climanomics® platform to provide climate risk analytics to clients across all sectors, including global financial services leaders, industrial corporations, and energy providers. "At a time when markets and investors are demanding climate risk transparency and quantification, IBM is committed to providing cloud-based climate risk solutions to the financial services sector and critical infrastructure industries such as industrial, consumer, energy, and utilities," said Dr. Murray Simpson, IBM's Global Lead for Sustainability, Climate & Transition. "This collaboration with The Climate Service will provide clients financial insights that are based on the most advanced available science and technology. As we work with clients to integrate critical insights into their business decision-making, our goal is to inform their strategy and help them remain competitive and resilient." "With the TCFD framework now supported by organizations globally, demand for the Climanomics® platform has been growing fast," says James McMahon, CEO of The Climate Service. "With IBM's advanced technology and global experience, this work will scale quickly so we can accelerate progress on our mission to embed climate risk into global decision-making." "Climate change presents the markets, as well as society as a whole, with an exponential challenge. Through this collaboration we will offer solutions using the power of world-class science and technology," continued McMahon. IBM and TCS signed their alliance agreement in October 2019, and the two companies have been collaborating for the past year, building a go-to-market strategy. This announcement is made on the heels of the collaboration reaching several milestones that enabled the TCS Climanomics® software platform to be available on Red Hat OpenShift on IBM Cloud, as well as the commencement of a joint effort to find ways to help global financial and energy companies measure climate risk. About The Climate ServiceThe Climate Service provides climate risk analytics to investors and businesses. With support from an unparalleled scientific team and advisors including four IPCC Nobel Prize-winning scientists, The Climate Service built its Climanomics® analytics platform to enable reporting and disclosure consistent with the TCFD framework. The platform empowers decision-making by putting a price on both transition and physical risk and supports long-term, strategic planning with 'one-click' property/asset and portfolio-level analysis, and multiple climate scenarios covering present-day to the year 2100. Insights from the platform help investors and businesses manage risk, build resilience, and drive change. Forrester Research named The Climate Service as "Leader", the highest designation possible, in its Climate Risk Analytics New Wave 2020. Contacts:Chris AndrewsIBM Communicationscandrews@us.ibm.com  Julianne HoganJulianne@benecomms.io Disclaimer This document is current as of the initial date of publication and may be changed by IBM at any time. Not all offerings are available in every country in which IBM operates.It is the user's responsibility to evaluate and verify the operation of any other products or programs with IBM products and programs. IBM products are warranted according to the terms and conditions of the agreements under which they are provided. SOURCE IBM

IBM, Fenergo to Transform New Customer Onboarding for Financial Institutions

AI and Analytics on IBM Cloud can help expedite customer lifecycle management and improves client experience ARMONK, N.Y., Oct. 5, 2020 /PRNewswire/ -- SIBOS: IBM (NYSE: IBM) and Fenergo, a leading provider of client lifecycle management (CLM) solutions for financial institutions, today announced the general availability of IBM Customer Lifecycle Management (CLM) with Fenergo. The offering is designed to incorporate artificial intelligence (AI) from IBM Watson and analytics on the IBM Cloud to help financial institutions drive efficiencies in customer onboarding through improved personalization, risk assessment and regulatory compliance. Onboarding a new client can often take weeks for a financial institution to complete. Research undertaken by Forrester and Fenergo showed financial institutions that have implemented only partial onboarding solutions spend between two and 12 weeks to complete the new client onboarding process. Additionally, significant financial penalties and sanctions can follow if anti-money laundering (AML) and know-your-client (KYC) regulations are not followed. The collaboration with Fenergo is one of many ways IBM is helping financial institutions reinvent the customer experience through digital transformation. Today, 9 out of 10 Fortune 500 banks and financial institutions use IBM Cloud, and IBM continues to help expand and strengthen its solution offerings, services and partnerships. IBM's RegTech portfolio of solutions applies the latest advancements in AI, machine learning and automation to the risk and compliance process, increasing operational efficiency, accelerating insight and improving transparency, while running on a hybrid cloud. IBM also continues to invest in hybrid cloud ecosystems, particularly for the financial services industry.  "Compliance can be time consuming and costly, often diverting resources from the core focus of improving the customer experience," said Likhit Wagle, General Manager; Global Banking of IBM. "Artificial Intelligence is ideally suited to redefine how regulatory compliance is addressed, and IBM Watson is leading that effort. Through our strong ecosystem of partners, we're helping to streamline these processes to allow banks, insurers and other financial providers to focus on their clients' needs first." Transforming Customer Onboarding with AI and Analytics IBM CLM with Fenergo is designed to enable financial institutions to provide a single, connected client journey from initial interaction through to investor or fund onboarding and lifecycle events. It fuses Fenergo's leading expertise in digital transformation, customer journey and CLM experience as well as its regulatory workflow with IBM's RegTech Watson-powered portfolio of AML and KYC solutions. "In today's challenging business environment, financial institutions should look for a CLM system that automates regulatory compliance while delivering optimum customer experiences," said Julian Clarke, Head of Partners and Alliances at Fenergo. "Through our relationship with IBM, financial institutions can benefit from our combined experience and industry leading technology to digitally transform customer journeys and help reduce the burden of regulatory compliance." The offering is designed to incorporate analytics on the IBM Cloud to help assess the risk profile of a new customer, such as geography, money-movement behavior and network, as well as AI built on IBM Watson to compile an analysis of the customer's reputation based on publicly available information.  As a result, it can help streamline the risk assessment process, enable seamless digital interactions, reduce manual intervention due to unnecessary errors, and free up clients to focus more on addressing the needs of successfully vetted customers.  Partner Ecosystems Key to Driving Industry Transformation Central to the collaboration is IBM's commitment to its partner ecosystem that helps to accelerate transformation across industries. In addition to collaborating with Fenergo, IBM can drive adoption of IBM CLM with Fenergo through its global alliance with Salesforce. "Financial institutions know first-hand how onboarding new clients can be a significant pain point," said Rohit Mahna, senior vice president and general manager of financial services at Salesforce. "Our global alliance with IBM puts us in a unique position to deliver this powerful technology with Fenergo to a significant portion of the financial sector. This kind of innovation is what our partnership with IBM is all about, and it's instrumental in how we drive synergies that enable industry-wide transformation." Geared toward a multitude of financial institutions – insurance, mortgage lending, wealth and asset management, and retail – the offering can be run on premises or on IBM Cloud, adding deployment flexibility that can help meet the hybrid cloud needs of today's financial services client. For more information about how to get started with IBM CLM with Fenergo, click here. Media Contact:Christina Trejo848.702.4607Christina.Trejo@ibm.com SOURCE IBM

IBM Watson Health and OrbitalRX to Launch Integrated Solution to Assist Hospital Pharmacy Providers in Managing Drug Shortages

Joint offering pairs pharmacy supply chain management capabilities with evidence-based drug content, designed to help hospital pharmacy teams manage drug shortages CAMBRIDGE, Mass. and WINSTON-SALEM, N.C., Sept. 1, 2020 /PRNewswire/ -- IBM (NYSE: IBM) Watson Health and OrbitalRX® today announced a strategic collaboration that aims to help address the emerging drug shortage crisis. The companies are combining OrbitalRX's Drug Shortage Management Platform and IBM® Micromedex® into one unified solution called "OrbitalRX and Micromedex," designed to create a single source for healthcare providers and pharmacy teams to access evidence-based treatment information alongside a hospital's current drug inventory status and drug sourcing options. This one solution aims to quickly analyze the supply chain and identify clinical alternatives for drugs that are in short supply. The global drug shortage crisis has accelerated at an alarming rate during the COVID-19 crisis. According to the American Society of Health-Systems Pharmacists (ASHP), close to 200 drugs are currently on the drug shortage list in the U.S. alone. Management of these shortages is further complicated by the fact that shortages vary by drug and location, as noted by the American Medical Association (AMA). The new solution, OrbitalRX and Micromedex, will be designed to evaluate important drug information, clinical evidence, and comparative efficacy, alongside the hospital's drug inventory, purchase history, and utilization data, enabling hospital providers, pharmacists and pharmacy technicians to proactively manage drug shortages. "As hospitals around the world experience shortages of life-saving therapies, there is an immediate, critical need for evidence-based information around clinical alternatives," said Todd Nolen, General Manager, IBM Micromedex Solutions, IBM Watson Health. "We are addressing this critical need by combining our Micromedex content with powerful insights from the OrbitalRX platform. Our goal is to deliver a trusted platform to help pharmacists and other healthcare providers streamline workflow and rapidly respond to drug shortages with appropriate, safe and effective alternative therapies." IBM Micromedex is one of the largest online reference databases for medication information. It is used by more than 4,500 hospitals and health systems worldwide to help support decision-making in medication therapy management, disease and condition management, toxicology, alternative medicine and patient education. OrbitalRX is the only platform designed by hospital pharmacists, for hospital pharmacists, to unify supply chain and clinical utilization to manage drug shortages and deliver the power of real-time situational awareness in hospital pharmacy workflows. "Patient safety can be compromised by supply chain interruptions, limited drug access due to high medication costs, and unforeseen events like COVID-19. OrbitalRX and Micromedex aim to help health system pharmacy departments mitigate these workflow challenges by identifying drug alternatives from a clinical and supplier perspective," said OrbitalRX co-founder and CEO, Adam Orsborn, PharmD, MS. "Rooted in cloud-based technology and evidence-based insights, this new, unified solution is designed to deliver workflow efficiencies that will empower pharmacists and providers to prioritize therapeutic needs."  "Hospital resources are scarcer than ever, especially with drug shortages and supply chain inefficiencies conspiring daily to upend the rigorous efforts of health systems to improve care quality while reducing cost," said OrbitalRX co-founder and Chief Product Officer, Nate Peaty, PharmD, MS. "With these challenges in mind, OrbitalRX and Micromedex plan to provide health systems with a highly intelligent and automated solution designed to help them with one of the most frustrating issues they face today."   OrbitalRX and Micromedex is anticipated to be available in Q4 2020. Please visit www.ibm.com/products/orbitalrx-micromedex.com to learn more about the solution, schedule a live demo, or to register for a webinar on September 24 to learn more. About IBM Watson HealthIBM Watson Health is a data, analytics, and technology partner for the health industry. Supported by the innovation of IBM and intelligence of Watson, we are committed to helping build smarter health ecosystems. Through the combination of our deep industry expertise in health, data and analytics, actionable insights, and reputation for security and trust, Watson Health is working together with its clients and partners to help them achieve simpler processes, better care insights, faster breakthroughs, and improved experiences for people around the world. Learn more at www.ibm.com/watson-health. For more information about IBM visit, www.ibm.com. Statements regarding IBM's future direction and intent are subject to change or withdrawal without notice and represent goals and objectives only.  About OrbitalRX Co-founded by health-system pharmacy leaders, OrbitalRX offers a one-of-a-kind drug shortage management platform which helps to identify risk factors using internal and external data for when a medication shortage could cause harm in your health-system. We offer everything you need to anticipate, evaluate, take action, follow-up, and report in a single, powerful platform designed to improve your overall shortage management strategy. To learn more about how we're changing the way hospital pharmacies monitor their supply and manage shortages in the supply chain, visit www.orbitalrx.com.   IBM Media ContactMatthew Henson917-930-7147matthew.henson@ibm.com OrbitalRX Media Contact  Emily Nichols emily@orbitalrx.com SOURCE IBM Watson Health